Current surgical treatment of nonsmall cell lung cancer 2001 Source: Eur Respir J 2002; 19: 61S-70S Year: 2002
Comparison of non-small cell lung cancer (NSCLC) management and survival in 1995 and 2005 at a London teaching hospital Source: Annual Congress 2008 - Management, quality aspects and prognosis in thoracic oncology Year: 2008
Survival trend of patients with lung cancer (LC) in Cáceres (Spain) (1991-2003). Analysis based on TNM staging, histology, modality-treatment and time-period of diagnosis Source: Eur Respir J 2007; 30: Suppl. 51, 669s Year: 2007
Stage, therapy and surviving of small cell lung cancer: analysis of a nonselected patient collective 1993-1997 Source: Eur Respir J 2001; 18: Suppl. 33, 394s Year: 2001
Preoperative physiological data and lung cancer surgery: do the same factors predict post-operative morbidity/mortality and long term survival? Source: Annual Congress 2005 - Prognostic factors in lung cancer Year: 2005
Follow-up and surveillance for lung cancer Source: Annual Congress 2005 - MP5 - Follow-up and surveillance for lung cancer Year: 2005
The analysis of lung cancer patients (LCP) survival during 5 year period after diagnosis of disease Source: Eur Respir J 2006; 28: Suppl. 50, 88s Year: 2006
Quality indicators in lung cancer care-review of resection rates in early stage NSCLC (non small cell lung cancer) at King’s Source: International Congress 2018 – Lung cancer: risk factors, supportive measures and quality improvement Year: 2018
Surrogate markers predicting overall survival for lung cancer: ELCWP recommendations Source: Eur Respir J 2011; 39: 9-28 Year: 2012
Surrogate markers predicting overall survival for lung cancer: ELCWP recommendations Source: Eur Respir J 2012; 39: 9-28 Year: 2012
Survival of patients resected for lung cancer in the period 1986 - 1977. Sensitivity of staging, prognostic factors, impact of adjuvant chemotherapy and radiotherapy Source: Eur Respir J 2001; 18: Suppl. 33, 230s Year: 2001
Efficacy of a pulmonary rehabilitation programme (PRP) after lung resection (LR) for cancer Source: Annual Congress 2005 - Pulmonary rehabilitation: an evidence-based intervention Year: 2005
The analysis of lung cancer patients (LCP) survival during one-year period after diagnosing of disease Source: Eur Respir J 2006; 28: Suppl. 50, 88s Year: 2006
Lung cancer in Berlin – NET of the lung; analysis of subgroups and impact on survival (2000 – 2008) Source: Annual Congress 2013 –Epidemiology, screening and diagnosis of lung cancer Year: 2013
Mortality of lung cancer in relation to respiratory symptoms, a 30-year population based study Source: Annual Congress 2005 - Assessing the relevance of obstructive airway diseases Year: 2005
Trends in drug costs and overall survival in patients diagnosed with metastatic non-small cell lung cancer (NSCLC) Source: International Congress 2019 – How to guide patients to reach a balance between costs and personal needs: quality indicators of effectiveness Year: 2019
Use of Bode index (BI) in patients with COPD undergoing inpatient pulmonary rehabilitation (IPR) after lung resection (LR) for non small cell lung cancer (NSCLC) Source: Eur Respir J 2006; 28: Suppl. 50, 70s Year: 2006
Lung cancer survival in the UK: are the results from the national lung cancer audit (LUCADA) dependent on completeness of case reporting? Source: Annual Congress 2009 - Epidemiology and management of lung cancer Year: 2009
A considerable reduction of the diagnostic delay from 2000 to 2008 has at most contributed to a modest improvement of survival in Danish lung cancer patients Source: Annual Congress 2009 - Epidemiology and management of lung cancer Year: 2009
Different mortality, recurrence and bleeding between cancer and non cancer patients with pulmonary embolism (PE): 1 year follow-up. Source: International Congress 2017 – Prognostic factors and outcomes in pulmonary embolism Year: 2017